Zinc finger nuclease: a new approach for excising HIV-1 proviral DNA from infected human T cells

2014 ◽  
Vol 41 (9) ◽  
pp. 5819-5827 ◽  
Author(s):  
Xiying Qu ◽  
Pengfei Wang ◽  
Donglin Ding ◽  
Xiaohui Wang ◽  
Gongmin Zhang ◽  
...  
2013 ◽  
Vol 41 (16) ◽  
pp. 7771-7782 ◽  
Author(s):  
Xiying Qu ◽  
Pengfei Wang ◽  
Donglin Ding ◽  
Lin Li ◽  
Haibo Wang ◽  
...  

2015 ◽  
Vol 44 (3) ◽  
pp. e30-e30 ◽  
Author(s):  
Jianbin Wang ◽  
Joshua J. DeClercq ◽  
Samuel B. Hayward ◽  
Patrick Wai-Lun Li ◽  
David A. Shivak ◽  
...  

Blood ◽  
2014 ◽  
Vol 123 (1) ◽  
pp. 61-69 ◽  
Author(s):  
Chuka A. Didigu ◽  
Craig B. Wilen ◽  
Jianbin Wang ◽  
Jennifer Duong ◽  
Anthony J. Secreto ◽  
...  

Key PointsZinc-finger nucleases simultaneously and permanently inactivate HIV coreceptors ccr5 and cxcr4 resulting in HIV-resistant CD4+ T cells. These HIV-resistant cells may be used to achieve a functional cure for HIV in humans.


Author(s):  
Friederike Knipping ◽  
Gregory A. Newby ◽  
Cindy R. Eide ◽  
Amber N. McElroy ◽  
Sarah C. Nielsen ◽  
...  

2008 ◽  
Vol 63 (1) ◽  
pp. 83-89 ◽  
Author(s):  
Yaseen A. Al-Soud ◽  
Haitham H. Al-Sa’doni ◽  
Houssain A. S. Amajaour ◽  
Kifah S. M. Salih ◽  
Mohammad S. Mubarakb ◽  
...  

A new series of coumarin and benzofuran derivatives were synthesized as potential non-nucleoside reverse transcriptase inhibitors (NNRTIs) by reacting, separately, 4-bromomethylcoumarins, their sulphonyl chlorides, and ethyl 3-(bromomethyl)-6-methoxy-1-benzofuran-2-carboxylate with different imidazoles and their benzo analogs. The antiviral (HIV-1, HIV-2) properties of the newly synthesized compounds were investigated in vitro and all compounds were found to be inactive, except 10 which showed inhibition of HIV-2 with EC50 > 0.51 μgmL−1. The in vitro cytotoxicity of 17 and 19 was assayed against a panel of tumor cell lines consisting of CD4 human T-cells.


1993 ◽  
Vol 13 (10) ◽  
pp. 6180-6189 ◽  
Author(s):  
M H Malim ◽  
B R Cullen

Although a great deal is known about the regulation of gene expression in terms of transcription, relatively little is known about the modulation of pre-mRNA processing. In this study, we exploited a genetically regulated system, human immunodeficiency virus type 1 (HIV-1) and its trans-activator Rev, to examine events that occur between the synthesis of pre-mRNA in the nucleus and the translation of mRNA in the cytoplasm. Unlike the majority of eukaryotic pre-mRNAs whose introns are efficiently recognized and spliced prior to nucleocytoplasmic transport, HIV-1 mRNAs containing functional introns must be exported to the cytoplasm for the expression of many viral proteins. Using human T cells containing stably integrated proviruses, we demonstrate that such incompletely spliced viral mRNAs are exported to the cytoplasm only in the presence of the Rev trans-activator. In the absence of Rev, these intron-containing RNAs are sequestered in the T-cell nucleus and either spliced or, more commonly, degraded. Because Rev does not inhibit the expression of fully spliced viral mRNA species in T cells, we propose that Rev, rather than inhibiting viral pre-mRNA splicing, is acting here both to prevent the nuclear degradation of HIV-1 pre-mRNAs and to induce their translocation to the cytoplasm. Taken together, these findings indicate that the cellular factors responsible for the nuclear retention of unspliced pre-mRNAs, although most probably splicing factors, do not invariably commit these RNAs to productive splicing and can, instead, program such transcripts for degradation.


1996 ◽  
Vol 7 (15) ◽  
pp. 1861-1869 ◽  
Author(s):  
Uwe Junker ◽  
Dorian Bevec ◽  
Carmen Barske ◽  
Creton Kalfoglou ◽  
Sonia Escaich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document